ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Positive Interim Data from ATH434-202 Phase 2 Clinical Trial, page-71

  1. 136 Posts.
    lightbulb Created with Sketch. 26
    It is obvious that the SP of ATH with over 5 Bln shares are controlled by the SP of ATHE with only less than 9 Mln ADRs!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.